HHLR Advisors’s Erasca ERAS Stock Holding History

HHLR Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,722,221	Closed	-$73.6M	–	72
2021 Q4	$73.6M	Hold	4,722,221	–	–	1.14%	19
2021 Q3	$100M	Buy	+4,722,221	New	+$97.4M	1.31%	16

Other funds holding ERAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

AEPBI

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

HHLR Advisors's ERAS Position: Q1 2022 in Review

HHLR Advisors sold out of Erasca (ERAS) in Q1 2022, closing a stake of 4,722,221 shares — an estimated $73.6M sold.

HHLR Advisors first reported a position in ERAS in Q3 2021 and held it in 2 quarters. The position peaked at $100M in Q3 2021. 82 funds tracked by Wall St. Rank hold ERAS as of Q1 2022.

HHLR Advisors reported no remaining Erasca position as of Q1 2022 after selling out during the quarter.
HHLR Advisors sold 4,722,221 Erasca shares in Q1 2022, an estimated $73.6M.
HHLR Advisors first reported a position in Erasca in Q3 2021 and held it in 2 quarters.
HHLR Advisors's Erasca position peaked at $100M in Q3 2021.
82 funds tracked by Wall St. Rank held Erasca as of Q1 2022.

Based on HHLR Advisors's 13F filing for Q1 2022, filed 16 May 2022.